Trademark: 97728407
Word
PURIST
Status
Pending
Status Code
686
Status Date
Tuesday, April 9, 2024
Serial Number
97728407
Mark Type
4000
Filing Date
Thursday, December 22, 2022
Published for Opposition
Tuesday, April 9, 2024

Trademark Owner History
GENECENTRIC THERAPEUTICS, INC. - Owner At Publication

Classifications
5 Assays for the medical diagnostic, prognostic and predictive testing of tumors; diagnostic preparations for medical purposes; medical diagnostic reagents; medical diagnostic reagents and assays for testing tissue samples; biological preparations for the detection, diagnosis, subtyping and monitoring of cancer
44 Medical testing services for diagnosis, prognosis, treatment, and management of cancer; Medical testing for diagnostic and treatment option purposes; Providing molecular genetics and genomics testing and reporting services in the field of biomarkers for the diagnosis, prognosis, treatment or management of cancer; Provision of health care services, namely, providing oncological testing reports to physicians
42 Providing medical and scientific research in the field of oncology, tumor biology, and diagnosis and treatment of cancers; Pharmaceutical research services; Providing medical research and scientific research information in the field of oncology; Providing medical and scientific research services in the field of cancer diagnosis, prognosis, therapy, prevention, treatment and patient management; Providing research and development services in the field of oncology; Research and development in the field of RNA expression, namely, cancer biology; Research and development services for others, namely, research and development of assays for oncological testing and diagnostic purposes; Scientific research in the field of RNA expression analysis and reporting; Providing laboratory research services in the field of pancreatic cancer; Research and development in the fields of biomarker discovery and validation; Medical and scientific research in the field of biomarker discovery in cancer patients; Pharmaceutical and medical research in the field of survival outcomes and standard of care research; Medical research featuring the identification and validation of cancer related biomarkers and RNA expression for use in improved patient outcomes; Providing a website and information in the field of medical research and scientific research in the fields of tumor biology, oncology, and diagnosis and treatment of cancers;

Trademark Events
Apr 9, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 9, 2024
Published For Opposition
Mar 20, 2024
Notification Of Notice Of Publication E-Mailed
Mar 4, 2024
Approved For Pub - Principal Register
Mar 1, 2024
Teas/Email Correspondence Entered
Mar 1, 2024
Correspondence Received In Law Office
Mar 1, 2024
Teas Response To Office Action Received
Dec 19, 2023
Application Extension Granted/Receipt Provided
Dec 19, 2023
Application Extension To Response Period - Received
Sep 22, 2023
Notification Of Non-Final Action E-Mailed
Sep 22, 2023
Non-Final Action E-Mailed
Sep 22, 2023
Non-Final Action Written
Sep 22, 2023
Assigned To Examiner
Jan 19, 2023
New Application Office Supplied Data Entered
Dec 26, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24